Methamphetamine

Methamphetamine

SCHEMBL8098367

CC(C)NC(C)C.CN[C@@H](C)Cc1ccccc1.Cl.[LiH]

nearest known ligand 0.78

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Methamphetamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SLC6A4 known ✓ P31645 1/20 0.49
SIGMAR1 Q99720 7/20 0.78
TAAR1 Q96RJ0 3/20 0.78
SLC18A2 Q05940 1/20 0.78
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
APEX1 P27695 1/20 0.49
PMP22 Q01453 1/20 0.49
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
TSHR P16473 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methamphetamine SCHEMBL9114797 0.90 SIGMAR1 (0.95) SIGMAR1TAAR1SLC18A2MEN1KMT2A
Methamphetamine SCHEMBL1608168 0.90 SIGMAR1 (0.95) SIGMAR1TAAR1SLC18A2MEN1KMT2A
Levmetamfetamine SCHEMBL42099 0.90 SIGMAR1 (0.95) SIGMAR1TAAR1SLC18A2MEN1KMT2A
Methamphetamine SCHEMBL42098 0.90 SIGMAR1 (0.95) SIGMAR1TAAR1SLC18A2MEN1KMT2A
Methamphetamine SCHEMBL42100 0.90 SIGMAR1 (0.95) SIGMAR1TAAR1SLC18A2MEN1KMT2A
Levmetamfetamine SCHEMBL9114800 0.90 SIGMAR1 (0.95) SIGMAR1TAAR1SLC18A2MEN1KMT2A
Methamphetamine SCHEMBL15094315 0.88 SIGMAR1 (1.00) SIGMAR1TAAR1SLC18A2MEN1KMT2A
Methamphetamine SCHEMBL13747483 0.88 SIGMAR1 (1.00) SIGMAR1TAAR1SLC18A2MEN1KMT2A
Methamphetamine SCHEMBL42615 0.88 SIGMAR1 (1.00) SIGMAR1TAAR1SLC18A2MEN1KMT2A
Methamphetamine SCHEMBL20211416 0.88 SIGMAR1 (1.00) SIGMAR1TAAR1SLC18A2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6040311-A TREATING BONE DISORDERS FOR PREVENTING OSTEOPOROSIS OR INHIBITING BONE RESORPTION IN A MAMMAL; TREATING TUMOR GROWTH IN A MAMMAL MERCK & CO., INC. (US) 2000-03-21 US disclosed
US-5952341-A VITRONECTIN RECEPTOR ANTAGONISTS FOR INHIBITING BONE RESORPTION, TREATING AND PREVENTING OSTEOPOROSIS, AND INHIBITING RESTENOSIS, DIABETIC RETINOPATHY, TUMOR, MACULAR DEGENERATION, ANGIOGENESIS, ATHEROSCLEROSIS, INFLAMMATION MERCK & CO., INC. (US) 1999-09-14 US disclosed